Ying Maggie Chen Lab

A major focus of our lab is to investigate the molecular pathogenesis of endoplasmic reticulum (ER) stress-mediated kidney diseases, to discover ER stress biomarkers, and to develop highly-targeted therapies by employing high-throughput drug screening.

Another focus is renal angiogenesis and fibrosis.

Dr. Chen in the News:

• Dr. Maggie Chen Receives UAB-UCSD O’Brien Center Pilot Award

• New Nanotechnique Monitors ER Stress Biomarker for ADTKD

• Dr. Ying Maggie Chen to Present at the 2021 FASEB ER Virtual Conference

• Ying Maggie Chen to Speak at Yale Symposium

• Ying Maggie Chen to Serve on ASN Grants Review Committee

• Ying Maggie Chen Appointed to FACA Nephrology Subcommittee

• Ying Maggie Chen Awarded NU GoKidney Grant

• Dr. Maggie Chen Receives $1.8M Department of Defense Grant to Develop Treatment for FSGS

• Dr. Ying Maggie Chen Awarded $300K Mallinckrodt Challenge Grant

• Ying Maggie Chen Receives Center for Drug Discovery Investigator Matching Grant

• Dr. Maggie Chen and Yeawon Kim Honored at OTM’s Annual Celebration of Inventors